Etiology and Status of Preventive Therapy of Cardioembolic Stroke: Hospital-Based Retrospective Analysis.
- Author:
Min Jeong KIM
1
;
Jong Moo PARK
;
Ji Young KIM
;
Byung Woo YOON
Author Information
1. Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. bwyoon@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Cerebral embolism;
Heart disease
- MeSH:
Atrial Appendage;
Atrial Fibrillation;
Cardiomyopathy, Dilated;
Foramen Ovale, Patent;
Heart Diseases;
Heart Ventricles;
Humans;
International Normalized Ratio;
Intracranial Embolism;
Korea;
Medical Records;
Myocardial Infarction;
Primary Prevention;
Prothrombin Time;
Retrospective Studies*;
Rheumatic Heart Disease;
Secondary Prevention;
Stroke*
- From:Journal of the Korean Neurological Association
2005;23(5):595-600
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The etiology of cardioembolic stroke in Korea tends to be different from western countries. This study is to assess the current trend in the etiology and prevention of cardioembolic stroke in Korea. METHODS: We reviewed the medical records of patients with cardioembolic stroke retrospectively from 1998 to 2003. The following items were examined: type of cardioembolic source, previous anticoagulation or antiplatelet therapy, previous stroke, insight of the heart disease, and the International Normalized Ratio (INR) value of prothrombin time (PT) on arrival. RESULTS: The cardioembolic sources of 226 patients were found to be of non-valvular atrial fibrillation in 100 (44.2%), a left ventricle regional wall motion abnormality (LV RWMA) in 45 (19.9%), rheumatic heart disease (RHD) in 34 (15.1%), patent foramen ovale in 18 (8.0%), left atrial appendage thrombi in 11 (4.9%), prosthetic valve in 10 (4.4%), dilated cardiomyopathy in 5 (2.2%), and recent myocardial infarction in 3 (1.3%). In 179 patients with no previous stroke, primary prevention was made in 52 (66.7%). Twenty-five (53.2%) out of 47 patients with stroke history were under secondary prevention. Among 39 patients who developed stroke in spite of anticoagulation, PT INR values of 27 (69.3%) were below 2.0. Proportions of RHD and LV RWMA were decreased and increased respectively. The rate of primary prevention, anticoagulation as secondary prevention, and adequate anticoagulation were also increased. CONCLUSIONS: The etiology of cardioembolic stroke in Korea seems to be changing according to the pattern of western countries. Many physicians are beginning to recognize the need for prevention of cardioembolism but more action is needed.
